View in EDS

Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929.

Saved in:
Bibliographic Details
Title: Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929.
Authors: Karim NA; Inova Schar Cancer Institute, Fairfax, Virginia; University of Virginia, Fairfax, Virginia. Electronic address: nagla.karim5@gmail.com., Miao J; SWOG Statistical Center and Data Management Center, Seattle, Washington; Fred Hutchinson Cancer Center, Seattle, Washington., Reckamp KL; Cedars-Sinai Medical Center, Los Angeles, California; Department of Thoracic Head and Neck Medical Oncology, The University of Texas Maryland., Gay CM; Anderson Cancer Center, Houston, Texas., Byers LA; Anderson Cancer Center, Houston, Texas., Zhao YQ; SWOG Statistical Center and Data Management Center, Seattle, Washington; Fred Hutchinson Cancer Center, Seattle, Washington., Redman MW; SWOG Statistical Center and Data Management Center, Seattle, Washington; Fred Hutchinson Cancer Center, Seattle, Washington., Carrizosa DR; Levine Cancer Institute, Charlotte, North Carolina., Wang WL; Department of Pathology, MD Anderson Cancer Center, The University of Texas Houston, Texas., Petty WJ; Wake Forest College, Winston-Salem, North Carolina., Mehta K; Medstar Georgetown Cancer Institute, Washington, District of Columbia., Faller BA; Missouri Baptist Medical Center, Saint Louis, Missouri., Agamah ES; Southern Illinois University, Springfield, Illinois., Kasbari SS; Southeastern Medical Oncology Center, Goldsboro, North Carolina., Malisetti RK; Minnesota Oncology Hematology PA - Coon Rapids, Minneapolis, Minneapolis., Kumar A; University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico., Schallenkamp J; Billings Clinic, Billings, Motana., Alluri KC; St. Luke's Cancer Institute, Boise, Idaho., Gray JE; Moffitt Cancer Center, Tampa, Florida., Kelly K; UC Davis Comprehensive Cancer Center, Sacramento, California.
Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2025 Mar; Vol. 20 (3), pp. 383-394. Date of Electronic Publication: 2024 Nov 04.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39505259
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Karim+NA%22">Karim NA</searchLink>; Inova Schar Cancer Institute, Fairfax, Virginia; University of Virginia, Fairfax, Virginia. Electronic address: nagla.karim5@gmail.com.<br /><searchLink fieldCode="AU" term="%22Miao+J%22">Miao J</searchLink>; SWOG Statistical Center and Data Management Center, Seattle, Washington; Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Reckamp+KL%22">Reckamp KL</searchLink>; Cedars-Sinai Medical Center, Los Angeles, California; Department of Thoracic Head and Neck Medical Oncology, The University of Texas Maryland.<br /><searchLink fieldCode="AU" term="%22Gay+CM%22">Gay CM</searchLink>; Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Byers+LA%22">Byers LA</searchLink>; Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Zhao+YQ%22">Zhao YQ</searchLink>; SWOG Statistical Center and Data Management Center, Seattle, Washington; Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Redman+MW%22">Redman MW</searchLink>; SWOG Statistical Center and Data Management Center, Seattle, Washington; Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Carrizosa+DR%22">Carrizosa DR</searchLink>; Levine Cancer Institute, Charlotte, North Carolina.<br /><searchLink fieldCode="AU" term="%22Wang+WL%22">Wang WL</searchLink>; Department of Pathology, MD Anderson Cancer Center, The University of Texas Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Petty+WJ%22">Petty WJ</searchLink>; Wake Forest College, Winston-Salem, North Carolina.<br /><searchLink fieldCode="AU" term="%22Mehta+K%22">Mehta K</searchLink>; Medstar Georgetown Cancer Institute, Washington, District of Columbia.<br /><searchLink fieldCode="AU" term="%22Faller+BA%22">Faller BA</searchLink>; Missouri Baptist Medical Center, Saint Louis, Missouri.<br /><searchLink fieldCode="AU" term="%22Agamah+ES%22">Agamah ES</searchLink>; Southern Illinois University, Springfield, Illinois.<br /><searchLink fieldCode="AU" term="%22Kasbari+SS%22">Kasbari SS</searchLink>; Southeastern Medical Oncology Center, Goldsboro, North Carolina.<br /><searchLink fieldCode="AU" term="%22Malisetti+RK%22">Malisetti RK</searchLink>; Minnesota Oncology Hematology PA - Coon Rapids, Minneapolis, Minneapolis.<br /><searchLink fieldCode="AU" term="%22Kumar+A%22">Kumar A</searchLink>; University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico.<br /><searchLink fieldCode="AU" term="%22Schallenkamp+J%22">Schallenkamp J</searchLink>; Billings Clinic, Billings, Motana.<br /><searchLink fieldCode="AU" term="%22Alluri+KC%22">Alluri KC</searchLink>; St. Luke's Cancer Institute, Boise, Idaho.<br /><searchLink fieldCode="AU" term="%22Gray+JE%22">Gray JE</searchLink>; Moffitt Cancer Center, Tampa, Florida.<br /><searchLink fieldCode="AU" term="%22Kelly+K%22">Kelly K</searchLink>; UC Davis Comprehensive Cancer Center, Sacramento, California.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101274235%22">Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer</searchLink> [J Thorac Oncol] 2025 Mar; Vol. 20 (3), pp. 383-394. <i>Date of Electronic Publication: </i>2024 Nov 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101274235 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1556-1380 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215560864%22">15560864 </searchLink><i>NLM ISO Abbreviation: </i>J Thorac Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39505259
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jtho.2024.10.021
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 383
    Titles:
      – TitleFull: Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Karim NA
      – PersonEntity:
          Name:
            NameFull: Miao J
      – PersonEntity:
          Name:
            NameFull: Reckamp KL
      – PersonEntity:
          Name:
            NameFull: Gay CM
      – PersonEntity:
          Name:
            NameFull: Byers LA
      – PersonEntity:
          Name:
            NameFull: Zhao YQ
      – PersonEntity:
          Name:
            NameFull: Redman MW
      – PersonEntity:
          Name:
            NameFull: Carrizosa DR
      – PersonEntity:
          Name:
            NameFull: Wang WL
      – PersonEntity:
          Name:
            NameFull: Petty WJ
      – PersonEntity:
          Name:
            NameFull: Mehta K
      – PersonEntity:
          Name:
            NameFull: Faller BA
      – PersonEntity:
          Name:
            NameFull: Agamah ES
      – PersonEntity:
          Name:
            NameFull: Kasbari SS
      – PersonEntity:
          Name:
            NameFull: Malisetti RK
      – PersonEntity:
          Name:
            NameFull: Kumar A
      – PersonEntity:
          Name:
            NameFull: Schallenkamp J
      – PersonEntity:
          Name:
            NameFull: Alluri KC
      – PersonEntity:
          Name:
            NameFull: Gray JE
      – PersonEntity:
          Name:
            NameFull: Kelly K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2025 Mar
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1556-1380
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
              Type: main
ResultId 1